Adaptive Biotechnologies
在场
高管
查看带有其 15 名主要高管的组织结构图
Adaptive Biotechnologies 搜索最多的简介
- Chad Robins, President, Chief Executive Officer and Director
- Robert Hershberg, Director
- Mike Pellini, Director
高管在Adaptive Biotechnologies变化
- Kyle Piskel 曾任 Principal Accounting Officer, 现升职为 Chief Financial Officer (新闻发布的2024四月4号).
- Tycho Peterson, Chief Financial Officer, 已经离开公司 (新闻发布的2024四月4号).
- Kevin Conroy, Director, 已经离开公司 (新闻发布的2023九月12号).
创建提醒
跟踪 Adaptive Biotechnologies 的高管变动
生物技术
Adaptive Biotechnologies 拥有 2,282 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Endeavor BioMedicines 刚刚宣布为 132 筹款数百万美元。 (公布2024四月25号).
- Metsera 刚刚宣布为 290 筹款数百万美元。 (公布2024四月23号).
- Histogen has filed for bankruptcy protection (公布2024四月19号).
生物技术 行业的其他推荐联系人
消息
Adaptive Biotechnologies 的最新新闻稿
- Events - Adaptive Biotechnologies
- Adaptive Biotechnologies to Report Third Quarter Financial Results on November 10, 2020 - Adaptive Biotechnologies
- Adaptive Biotechnologies to Present at the Morgan Stanley 2020 Healthcare Conference - Adaptive Biotechnologies
- Press Releases - Adaptive Biotechnologies
- Adaptive Biotechnologies Reports Second Quarter 2020 Financial Results - Adaptive Biotechnologies
- Adaptive Biotechnologies to Present at the UBS Genomics 2.0 and Medtech Innovations Summit - Adaptive Biotechnologies
- Adaptive Biotechnologies Receives Expanded FDA Clearance for the clonoSEQ® Assay to Assess Minimal Residual Disease (MRD) in Patients with Chronic Lymphocytic Leukemia - Adaptive Biotechnologies
- Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2 - Adaptive Biotechnologies
- Adaptive Biotechnologies Launches National Clinical Trial to Develop Novel T-Cell Based Diagnostic for Lyme Disease - Adaptive Biotechnologies
- Adaptive Biotechnologies Announces Pricing of Public Offering of Common Stock - Adaptive Biotechnologies
- View more press releases Close
通过电子邮件
